These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 10445673

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study.
    Bragadottir G, Redfors B, Ricksten SE.
    Crit Care Med; 2013 Oct; 41(10):2328-35. PubMed ID: 23921271
    [Abstract] [Full Text] [Related]

  • 4. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
    Harkin CP, Pagel PS, Tessmer JP, Warltier DC.
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
    [Abstract] [Full Text] [Related]

  • 5. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
    Pagel PS, Harkin CP, Hettrick DA, Warltier DC.
    Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency.
    Pagel PS, Hettrick DA, Warltier DC.
    Basic Res Cardiol; 1996 Oct; 91(4):296-307. PubMed ID: 8874779
    [Abstract] [Full Text] [Related]

  • 8. A comparison of hemodynamic effects of levosimendan and dobutamine in patients undergoing mitral valve repair / replacement for severe mitral stenosis.
    Gandham R, Syamasundar A, Ravulapalli H, Karthekeyan RB, Vakamudi M, Kodalli R, Nandipati S.
    Ann Card Anaesth; 2013 Oct; 16(1):11-5. PubMed ID: 23287080
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Hemodynamic effects of levosimendan following cardiac surgery].
    Alvarez J, Taboada M, Rodríguez J, Caruezo V, Bouzada M, Campaña O, Bascuas B, Pérez-Paz J, Ginesta V.
    Rev Esp Anestesiol Reanim; 2005 Oct; 52(7):389-94. PubMed ID: 16200918
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Levosimendan in aortic valve surgery: cardiac performance and recovery.
    Järvelä K, Maaranen P, Sisto T, Ruokonen E.
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):693-8. PubMed ID: 18922425
    [Abstract] [Full Text] [Related]

  • 13. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M, Lehtonen L.
    Curr Pharm Des; 2005 Oct; 11(4):435-55. PubMed ID: 15725064
    [Abstract] [Full Text] [Related]

  • 14. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.
    Edes I, Kiss E, Kitada Y, Powers FM, Papp JG, Kranias EG, Solaro RJ.
    Circ Res; 1995 Jul; 77(1):107-13. PubMed ID: 7788868
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
    Mehta RH, Leimberger JD, van Diepen S, Meza J, Wang A, Jankowich R, Harrison RW, Hay D, Fremes S, Duncan A, Soltesz EG, Luber J, Park S, Argenziano M, Murphy E, Marcel R, Kalavrouziotis D, Nagpal D, Bozinovski J, Toller W, Heringlake M, Goodman SG, Levy JH, Harrington RA, Anstrom KJ, Alexander JH, LEVO-CTS Investigators.
    N Engl J Med; 2017 May 25; 376(21):2032-2042. PubMed ID: 28316276
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.
    Nieminen MS, Akkila J, Hasenfuss G, Kleber FX, Lehtonen LA, Mitrovic V, Nyquist O, Remme WJ.
    J Am Coll Cardiol; 2000 Nov 15; 36(6):1903-12. PubMed ID: 11092663
    [Abstract] [Full Text] [Related]

  • 20. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
    Cholley B, Caruba T, Grosjean S, Amour J, Ouattara A, Villacorta J, Miguet B, Guinet P, Lévy F, Squara P, Aït Hamou N, Carillion A, Boyer J, Boughenou MF, Rosier S, Robin E, Radutoiu M, Durand M, Guidon C, Desebbe O, Charles-Nelson A, Menasché P, Rozec B, Girard C, Fellahi JL, Pirracchio R, Chatellier G, -.
    JAMA; 2017 Aug 08; 318(6):548-556. PubMed ID: 28787507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.